The Journal of infectious diseases
-
Randomized Controlled Trial Multicenter Study Comparative Study
A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis.
Syphilis remains an important source of morbidity worldwide. Long-acting penicillin is the only therapy currently recommended for syphilis in much of the world. Because of hesitation to use penicillin for fear of anaphylaxis, there is a need for an effective, well-tolerated alternative to penicillin for syphilis therapy. ⋯ In this trial, the efficacy of azithromycin at a dosage of 2.0 g administered orally was equivalent to that of benzathine penicillin G for the treatment of early syphilis in persons without HIV infection.